Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6951–7000 of 34725
On September 12, 2024, the board of directors (the “ Board ”) of Sarepta Therapeutics, Inc. (the “ Company ”) appointed Deirdre Connelly as a director of the Company, effective immediately, to serve as a member of Class I until the 2026 annual meeting of stockholders.
On September 16, 2024, the Board of Directors (the “Board”) of Dianthus Therapeutics, Inc. (the “Company”) appointed Steven Romano, M.D. as a Class III director of the Company and as a member of the Science and Technology Committee of the Board (the “S&T Committee”), effective immediately.
On September 12, 2024, Michael Griffin notified Rocket Lab USA, Inc. (the “Company”) of his retirement and resignation as a member of the Company’s Board of Directors and the Board Committees on which he serves effective immediately.
Mr. Mario Vázquez, one of the directors of the Company, died on August 3, 2024.
the appointment of Mr. Stelleo Tolda as a Class I director of the Company, to serve from September 12, 2024 until the Company’s 2025 Annual Meeting of Stockholders
each of Adam Morgan, Richard S. Eiswirth, Jr., Ross Demont, Michael Kaseta, Erin Parsons, Maggie Pax, Peter J. Pizzo, III and John Snisarenko ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
each of Adam Morgan, Richard S. Eiswirth, Jr., Ross Demont, Michael Kaseta, Erin Parsons, Maggie Pax, Peter J. Pizzo, III and John Snisarenko ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
each of Adam Morgan, Richard S. Eiswirth, Jr., Ross Demont, Michael Kaseta, Erin Parsons, Maggie Pax, Peter J. Pizzo, III and John Snisarenko ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
each of Adam Morgan, Richard S. Eiswirth, Jr., Ross Demont, Michael Kaseta, Erin Parsons, Maggie Pax, Peter J. Pizzo, III and John Snisarenko ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
each of Adam Morgan, Richard S. Eiswirth, Jr., Ross Demont, Michael Kaseta, Erin Parsons, Maggie Pax, Peter J. Pizzo, III and John Snisarenko ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
each of Adam Morgan, Richard S. Eiswirth, Jr., Ross Demont, Michael Kaseta, Erin Parsons, Maggie Pax, Peter J. Pizzo, III and John Snisarenko ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
each of Adam Morgan, Richard S. Eiswirth, Jr., Ross Demont, Michael Kaseta, Erin Parsons, Maggie Pax, Peter J. Pizzo, III and John Snisarenko ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
each of Adam Morgan, Richard S. Eiswirth, Jr., Ross Demont, Michael Kaseta, Erin Parsons, Maggie Pax, Peter J. Pizzo, III and John Snisarenko ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
On September 13, 2024, Thomas E. Davin informed BRC Inc. (the “Company”) of his decision to resign from the Company’s Board of Directors, effective September 13, 2024, in order to devote time to personal endeavors.
On September 12, 2024, the Board appointed Mr. Sean Menke to the Board.
On September 10, 2024, B. Ben Baldanza, a member of the Board of Directors (the “Board”) of JetBlue Airways Corporation (the “Company”) notified the Company that he decided to resign from the Board and, therefore, would not seek re-election to the Board at the Company’s 2025 Annual Meeting of Stockholders scheduled for May 2025.
On September 10, 2024, Edward Geiser was elected to the Board of Directors of the Company, effective September 10, 2024
On September 10, 2024, Telisa Toliver was elected to the Board of Directors of the Company, effective September 10, 2024
On September 13, 2024, the Board of Directors (the “Board”) of Arteris, Inc. (the “Company”) upon the recommendation of the Nominating and Corporate Governance Committee (“NCG Committee”), approved Joachim Kunkel to be appointed to the Board effective September 16, 2024.
Mr. Dierker will also join the Board as a director effective March 31, 2025.
On September 16, 2024 the Board of the Company appointed James S. Harper to the Board as trustee, effective as of September 16, 2024.
On September 16, 2024, Fabrizio Bocciardi, a trustee on the Board of Trustees (the “ Board ”) of Middle Market Apollo Institutional Private Lending (the “ Company ”), informed the Company of his decision to resign as a member of the Board, effective September 16, 2024.
On the Effective Date and immediately following the Conversion, the following individuals were appointed as Managers of the Company in accordance with the LLC Agreement: Brian Napack, Laurence Berg, Paul Lalljie, Jason Mudrick, Sean Britain, Bruce Emery, and Thomas C. Fleming.
On the Effective Date and immediately following the Conversion, the following individuals were appointed as Managers of the Company in accordance with the LLC Agreement: Brian Napack, Laurence Berg, Paul Lalljie, Jason Mudrick, Sean Britain, Bruce Emery, and Thomas C. Fleming.
On the Effective Date and immediately following the Conversion, the following individuals were appointed as Managers of the Company in accordance with the LLC Agreement: Brian Napack, Laurence Berg, Paul Lalljie, Jason Mudrick, Sean Britain, Bruce Emery, and Thomas C. Fleming.
On the Effective Date and immediately following the Conversion, the following individuals were appointed as Managers of the Company in accordance with the LLC Agreement: Brian Napack, Laurence Berg, Paul Lalljie, Jason Mudrick, Sean Britain, Bruce Emery, and Thomas C. Fleming.
On the Effective Date and immediately following the Conversion, the following individuals were appointed as Managers of the Company in accordance with the LLC Agreement: Brian Napack, Laurence Berg, Paul Lalljie, Jason Mudrick, Sean Britain, Bruce Emery, and Thomas C. Fleming.
On the Effective Date and immediately following the Conversion, the following individuals were appointed as Managers of the Company in accordance with the LLC Agreement: Brian Napack, Laurence Berg, Paul Lalljie, Jason Mudrick, Sean Britain, Bruce Emery, and Thomas C. Fleming.
On the Effective Date and immediately following the Conversion, the following individuals were appointed as Managers of the Company in accordance with the LLC Agreement: Brian Napack, Laurence Berg, Paul Lalljie, Jason Mudrick, Sean Britain, Bruce Emery, and Thomas C. Fleming.
On September 12, 2024, the Board of Directors (the “Board”) of LandBridge Company LLC (NYSE: LB) (the “Company”) appointed Andrea Nicolás to serve on the Board, with a term expiring at the Company’s 2025 annual meeting of shareholders.
Effective September 16, 2024, the Board of Directors has appointed Mr. Christopher Nicoll as a member of the Company's Board of Directors.
Effective September 16, 2024, Ms. Yuanmei Ma will resign from her positions as Chief Financial Officer and member of the Board of Directors of the Company.
Effective September 12, 2024, the Board of Directors (the “Board”) of AMC Entertainment Holdings, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee, fixed the number of directors constituting the Board at 11 directors and elected Marcus Glover as a Class I director to serve until the Company’s 2027 Annual Meeting of Stockholders.
On September 16, 2024, Wayne Kalish was appointed to the Board of Directors of iCoreConnect Inc., (the “Company”).
James L. Cox, M.D., and Joan B. Harvey resigned from the Company’s board of directors.
the Company’s board of directors appointed Sundeep Agrawal, M.D. as a Class B director.
James L. Cox, M.D., and Joan B. Harvey resigned from the Company’s board of directors.
the Board approved the appointment of Mr. James C. DiPrima, the Company’s Interim Chief Executive Officer and Interim Chief Financial Officer, to its Board of Directors.
accepted the resignation of Hassan Oulhous as a member of the Company’s Board of Directors.
On October 13, 2023, Farmhouse announced that Mr. Scott Bosick, a member of the Board of Directors, tendered his resignation from the Board, effective immediately.
On the same day, October 13, 2023, the Board appointed Ms. Leslie R. Katz as an Independent Director, succeeding Mr. Bosick.
Effective August 22, 2024, James Fuller voluntarily resigned as a Director of Cavitation Technologies, Inc. (“Company”) and any committees thereof for personal reasons.
On September 15, 2024, Chunyi (Amy) Leong informed SkyWater Technology, Inc. (the “Company”) of her decision to resign from the Company’s Board of Directors (the “Board”) effective September 29, 2024.
Dr. Ford Tamer, a member of the Board of Directors of Marvell Technology, Inc. (the “Company”), notified the Company of his decision to resign from the Board effective as of September 15, 2024.
On September 12, 2024, Suzanne Blaug, Benjamin Cravatt, and Gerald Lema each provided to the Board of Directors (the “Board”) notification of their resignations from the Board of FibroGen, Inc. (the “Company”), effective September 30, 2024.
On September 12, 2024, Suzanne Blaug, Benjamin Cravatt, and Gerald Lema each provided to the Board of Directors (the “Board”) notification of their resignations from the Board of FibroGen, Inc. (the “Company”), effective September 30, 2024.
On September 12, 2024, Suzanne Blaug, Benjamin Cravatt, and Gerald Lema each provided to the Board of Directors (the “Board”) notification of their resignations from the Board of FibroGen, Inc. (the “Company”), effective September 30, 2024.
the Board of Directors of the Registrant appointed Felton Magee, Jr. as director effective September 12, 2024, to fill the vacancy in the class of directors with terms of office expiring at the 2025 Annual Meeting of Stockholders and until his successor is duly elected and qualifies.
On September 11, 2024, Ms. Nikita Jaiswal resigned from the board of directors (the “Board”) of Future Health Esg Corp (the “Company”).
On September 10, 2024, Eva Redhe, an independent director on the Board of Directors of Enphys Acquisition Corp., a Cayman Islands exempted company (the “Company”), informed the Company that she has resigned from the Board of Directors of the Company, including from her committee positions on the audit committee, the compensation committee, and the nominating and corporate governance committee, effective immediately.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.